These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4632374)

  • 21. Efficacy of phosphonomycin in treatment of urinary-tract infections.
    Barnett JA; Southern PM; Luby JP; Sanford JP
    Antimicrob Agents Chemother (Bethesda); 1969; 9():349-51. PubMed ID: 4918996
    [No Abstract]   [Full Text] [Related]  

  • 22. Gentamicin. Clinical and pharmacological studies.
    Holloway WJ
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):122-7. PubMed ID: 4913081
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy ofrary tct infections with Nicene (a quinoline--sulfanilamide preparation)].
    Metz H; Flogaus K
    Munch Med Wochenschr; 1969 Oct; 111(41):2099-102. PubMed ID: 4900861
    [No Abstract]   [Full Text] [Related]  

  • 24. [Choice of antibiotics in infections of the urinary tract].
    Yourassowsky E
    Acta Urol Belg; 1971; 39(4):533-7. PubMed ID: 4950454
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa with exceptionally high resistance to gentamicin in hospital wards. Susceptibility and phage typing.
    Yourassowsky E; Schoutens E; Beumer J
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):927-9. PubMed ID: 5003572
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibacterial in vitro and in vivo activity of a new tetracycline: CL 59806].
    Renzini G; Bevilacqua RL; Boemi G; Ravagnan L
    Antibiotica; 1967 Dec; 5(4):241-61. PubMed ID: 4900571
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
    Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in patterns and resistances of bacteria from 731 patients with bacteremia in 11 years].
    Xin J; Xiang Y; Zhang J
    Zhonghua Yi Xue Za Zhi; 1997 May; 77(5):332-5. PubMed ID: 9772485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indications for gentamicin therapy.
    Lindqvist B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:149-. PubMed ID: 4591710
    [No Abstract]   [Full Text] [Related]  

  • 32. Sodium colistimethate (Coly-mycin).
    Med Lett Drugs Ther; 1968 Nov; 10(23):96. PubMed ID: 4307656
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bacteremia and sepsis caused by Escherichia coli and other gram negative bacilli].
    Falisevac J; Schönwald S; Car V
    Lijec Vjesn; 1970; 92(2):149-67. PubMed ID: 4919347
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pneumonia caused by Pseudomonas aeruginosa].
    Kozaczek W; May K
    Pol Tyg Lek; 1971 May; 26(19):725-6. PubMed ID: 4997246
    [No Abstract]   [Full Text] [Related]  

  • 35. [Trimethoprim and sulfamethoxazole (Eusaprim) in chronic urinary tract infections].
    Porpáczy P
    Wien Klin Wochenschr; 1971 Jun; 83(24):439-41. PubMed ID: 4942385
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cephalexin monohydrate in the treatment of bone and soft tissue infections].
    Hernandez B; Bravo PA; Zarraga J; Fernandez A; Cruz Cruz M; Añorve I; Martinez J
    Prensa Med Mex; 1970; ():32-5. PubMed ID: 4931113
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 38. Nalidixic acid in urinary infection.
    Neogy KN; De MS; Chatterjee ML
    Bull Calcutta Sch Trop Med; 1968 Jan; 16(1):11-2. PubMed ID: 4890385
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.
    DeRyke CA; Kuti JL; Nicolau DP
    Pharmacotherapy; 2007 Mar; 27(3):333-42. PubMed ID: 17316145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Colistinmethane sulfate. Its antibacterial activity against Pseudomonas aeruginosa and Escherichia coli and its effective blood levels in adults].
    Auwärter W
    Arzneimittelforschung; 1965 Jun; 15(6):595-604. PubMed ID: 5328582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.